Insurance price ceiling reeval results to be notified soon
By Lee, Tak-Sun | translator Kim, Jung-Ju
23.05.09 05:50:52
가나다라
0
DREC deliberations were completed on the 4th...a month behind the original schedule
Results disclosed after 2nd DREC deliberations...list to be amended after negotiations

The Health Insurance Review and Assessment Service completed its first review on drugs subject to primary pricing ceiling reevaluations and will be notifying companies of the results soon.
A 30-day objection period will follow HIRA’s result notification.
According to HIRA on the 8th, HIRA’s Drug Reimbursement Evaluation Committee completed its first review of drugs subject to pricing ceiling reevaluations and will notify companies of the results within the week. About 14,000 items from about 200 companies were subject to primary evaluations.
According to the original schedule, HIRA was supposed to complete the first evaluation and DREC review in April, but the pe
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)